This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WESLEY W. SPINK, M.D.

AMA Arch Intern Med. 1954;94(2):167-196.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

PENICILLIN was injected for the first time into a human patient having an infection on Feb. 12, 1941.³⁷ The patient had severe staphylococcal sepsis and improved considerably, but he died subsequently because of the very limited supply of penicillin. Shortly thereafter, with more antibiotic available, penicillin proved to be extraordinarily effective for the treatment of staphylococcal disease. As a consequence, the mortality rate for staphylococcal septicemia was sharply reduced, and chronic debilitating disease was decreased in those who recovered. But within a decade penicillin was to lose much of its therapeutic effectiveness for staphylococcal sepsis, and, regardless of the advancements made with other antibiotics, the mortality rates from staphylococcal septicemia in many clinics today approach and even surpass 50% of the cases. Many of the disappointing clinical results with penicillin and other antibiotics have been due to the appearance of strains of staphylococci resistant to the antibacterial action of . . . [Full Text PDF of this Article]

Author Affiliations
MINNEAPOLIS

Footnotes
Professor of Medicine, University of Minnesota Medical School.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?